The mm Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the mm Hub cannot guarantee the accuracy of translated content. The mm and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Multiple Myeloma Hub is an independent medical education platform, sponsored by Bristol Myers Squibb, GSK, Johnson & Johnson, Pfizer, Roche and Sanofi. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View mm content recommended for you
The 23rd Congress of the European Hematology Association (EHA) abstract deadline
The 23rd Congress of the European Hematology Association (EHA) will be held in Stockholm, Sweden at the Stockholmsmässan Congress Center from 14–17 June 2018. Abstract submission is due to close on 1 March 2018 at 23:59 CET; the deadline for EHA attendance registration is 10 May 2018.
On the EHA website, it states that: “the 23rd Congress of EHA will offer you a program covering every subspecialty in hematology, as well as network opportunities with experts from all over the globe. The educational and scientific program will highlight state-of-the-art clinical practice, the latest findings in hematology research and many more interesting sessions. The Congress also provides satellite programs, Updates-in-Hematology and an exhibition organized by pharmaceutical companies."
The Multiple Myeloma Hub will be covering key highlights from EHA 2018 during the congress including oral sessions, late-breaking abstracts, and educational sessions, with a focus on the latest lymphoma research that impacts clinical practice.
References